About Medlac Pharma
Medlac Pharma is a company based in Hanoi (Vietnam) founded in 2008 was acquired by Hikma in November 2018. Medlac Pharma offers products and services including Vial Production and Ampoule Production. Medlac Pharma operates in a competitive market with competitors including Exela Pharma, Gland Pharma, August Bioservices, ApiJect and Vetter Pharma, among others.
- Headquarter Hanoi, Vietnam
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Medlac Pharma Italy Co.,Ltd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medlac Pharma
Medlac Pharma offers a comprehensive portfolio of products and services, including Vial Production and Ampoule Production.
Produces vials for pharmaceutical drug storage and delivery.
Manufactures ampoules for sterile liquid medications.
Funding Insights of Medlac Pharma
Detailed funding history for Medlac Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Medlac Pharma
Medlac Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Hikma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Generics and pharmaceutical products are manufactured by Hikma.
|
Locked | Locked | Locked |
Investor details for Medlac Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medlac Pharma
Investment portfolio details for Medlac Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medlac Pharma
Detailed financials for Medlac Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medlac Pharma Comparisons
Peer comparison for Medlac Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medlac Pharma
Medlac Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exela Pharma, Gland Pharma, August Bioservices, ApiJect and Vetter Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| Locked | Locked | Locked |
Generic injectable drugs are manufactured across therapeutic segments.
|
|
| Locked | Locked | Locked |
Diversified research services for clinical solutions are offered.
|
|
| Locked | Locked | Locked |
Medicine injectors are manufactured by ApiJect for medical applications.
|
|
| Locked | Locked | Locked |
CDMO specializing in aseptically prefilled syringe systems, cartridges and vials.
|
|
| Locked | Locked | Locked |
Injectable drug products are manufactured by this biopharma CDMO.
|
Detailed competitors of Medlac Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medlac Pharma
Complete news archive for Medlac Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medlac Pharma
Medlac Pharma was founded in 2008.
Medlac Pharma is headquartered in Hanoi, Vietnam.
Alfonso Sciotti is the current CEO of Medlac Pharma.
Medlac Pharma was founded in 2008 and is based in Hanoi, Vietnam. Operations focus on the pharmaceutical sector, where parenteral products are developed and manufactured. Therapeutic categories covered include analgesics such as NSAIDs, cardiovascular agents, antibiotics, antidotes, corticosteroids, anesthetics, nootropics, muscle relaxants, multivitamins, and additional areas. The company serves these needs through standard production processes in the region.
Medlac Pharma's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.
Medlac Pharma offers Vial Production and Ampoule Production.
Medlac Pharma has 1 investor. Key investors include Hikma.